INT-767 also reduced hypercholesterolemia by FXR activation and induced thermogenic gene expression through TGR5 and/or FXR activation, which led to the reversal of the HFD-induced metabolic disorders [134]. This evidence concerns the gene GPBAR1 and metabolic disease.